SEARCH

SEARCH BY CITATION

References

  • 1
    Kahan BD. Cyclosporin A. FK506, rapamycin: The use of a quantitative analytic tool to discriminate immunosuppressive drug interactions. J Am Soc Nephrol 1992; 2(12 Suppl): S222S227.
  • 2
    Kahan BD. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: A randomized multicentre study. The Rapamune US Study Group. Lancet 2000; 356: 194202.
  • 3
    Shihab FS, Bennett WM, Yi H, Choi SO, Andoh TF. Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity. Kidney Int 2004; 65: 12621271.
  • 4
    MacDonald A. Improving tolerability of immunosuppressive regiments. Transplantation 2001; 72(12 Suppl): S105S112.
  • 5
    Van Hooff JP, Squifflet JP, Wlodarczyk Z, Vanrenterghem Y, Paczek L. A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients. Transplantation 2003; 75: 19341939.
  • 6
    Mendez R, Gonwa T, Yang HC, Weinstein S, Jensik S, Steinberg S, Prograf Study Group. A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 1 year. Transplantation 2005; 80: 303309.
  • 7
    Kobashigawa JA, Miller LW, Russell SD et al. Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. Am J Transplant 2006 (in press).
  • 8
    Meier-Kriesche HU, Schold JD, Srinivas TR, Howard RJ, Fujita S, Kaplan B. Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. Am J Transplant 2005; 5: 22732280.
  • 9
    Khwaja K, Asolati M, Harmon J et al. Outcome at 3 years with a prednisone-free maintenance regimen: A single-center experience with 349 kidney transplant recipients. Am J Transplant 2004; 4: 980987.
  • 10
    Gallon L, Perico N, Dimitrov B et al. Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. Am J Transplant 2006; 6: 16171623.